- Home
- APEI vs ATXS Comparison
APEI vs ATXS Comparison
Compare APEI & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APEI
- ATXS
- Stock Information
- Founded
- APEI 1991
- ATXS 2008
- Country
- APEI United States
- ATXS United States
- Employees
- APEI N/A
- ATXS N/A
- Industry
- APEI Other Consumer Services
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- APEI Consumer Discretionary
- ATXS Health Care
- Exchange
- APEI Nasdaq
- ATXS Nasdaq
- Market Cap
- APEI 433.7M
- ATXS 401.2M
- IPO Year
- APEI 2007
- ATXS 2015
- Fundamental
- Price
- APEI $24.83
- ATXS $5.36
- Analyst Decision
- APEI Strong Buy
- ATXS Strong Buy
- Analyst Count
- APEI 5
- ATXS 6
- Target Price
- APEI $25.75
- ATXS $30.00
- AVG Volume (30 Days)
- APEI 151.6K
- ATXS 528.1K
- Earning Date
- APEI 05-12-2025
- ATXS 05-12-2025
- Dividend Yield
- APEI N/A
- ATXS N/A
- EPS Growth
- APEI N/A
- ATXS N/A
- EPS
- APEI 0.55
- ATXS N/A
- Revenue
- APEI $624,559,000.00
- ATXS N/A
- Revenue This Year
- APEI $6.97
- ATXS N/A
- Revenue Next Year
- APEI $3.26
- ATXS N/A
- P/E Ratio
- APEI $45.15
- ATXS N/A
- Revenue Growth
- APEI 4.00
- ATXS N/A
- 52 Week Low
- APEI $11.80
- ATXS $3.56
- 52 Week High
- APEI $25.76
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- APEI 59.49
- ATXS 56.04
- Support Level
- APEI $21.98
- ATXS $5.01
- Resistance Level
- APEI $25.76
- ATXS $5.35
- Average True Range (ATR)
- APEI 1.36
- ATXS 0.32
- MACD
- APEI 0.02
- ATXS 0.18
- Stochastic Oscillator
- APEI 76.21
- ATXS 92.88
About APEI American Public Education Inc.
American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.